Delivery Order SPE2DB22D3301-SPE2DB25FX8NP
Award Date
1/15/25
Potential Completion Date
1/16/25
Potential Value
$19K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,587.93 firm fixed-price delivery order is for the supply of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product. The contract has an ultimate completion date of January 8, 2025.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,475.69 Firm Fixed Price Delivery Order covers the supply of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product, with a performance period ending on January 9, 2025. The contract is not designated as a set-aside.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,627.76 firm fixed-price delivery order is for the supply of 4566963200 units of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2025.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,355.78, is a delivery order for the supply of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product.
The contract has an ultimate completion date of November 1, 2024 and was awarded on October 31, 2024. It is a firm fixed price contract with no set-aside designation, indicating open...
This federal contract award, valued at $11,047.18, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4566477089 MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of November 19, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division. The $6,010.54 firm-fixed-price delivery order is for the supply of 4565684248 units of the pharmaceutical product MESTINON 180 MG TIMESPAN UU 30S. The contract has an ultimate completion date of September 5, 2024.
Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal...
This federal contract award is for the delivery of Mestinon 180 mg Timespan tablets to the Defense Logistics Agency (DLA). The $8,426.09 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 18, 2024, with a completion date of December 19, 2024. The contract is not designated as a set-aside.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,363.72, is for the delivery of Mestinon 180 mg Timespan capsules. It is a firm-fixed-price delivery order with an ultimate completion date of October 22, 2024. The contract does not have a set-aside designation, indicating open competition.
AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,415.08, is for the provision of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product. There is no set-aside designation on this contract.
Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $4,419.66 Firm Fixed Price delivery order is for the supply of 4,564,340 units of the prescription medication Mestinon 180 mg Timespan with an ultimate completion date of April 22, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a wide range...